Skip to main content
logo
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.030
+0.080 (4.10%)
At close: Jul 27, 2026, 4:00 PM EDT
2.050
+0.020 (0.99%)
After-hours: Jul 27, 2026, 7:34 PM EDT

Palisade Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.25--
Revenue Growth
------
Gross Profit
---0.25--
Operating Income
-26.49-18.06-14.86-13.07-15.72-41.85
Net Income
-24.15-16.78-14.44-12.3-14.26-26.62
Earnings Per Share
0.07-0.30-10.19-20.37-247.95-2546.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
132.63133.399.8212.4312.3810.5
Total Debt
00.070.170.370.40.2
Net Cash (Debt)
132.63133.319.6512.0611.9810.3
Net Cash Growth
1749.25%1281.21%-19.99%0.70%16.35%-
Net Cash Per Share
1.242.396.8112.21204.12826.07

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.31-10.85-12.19-11.13-13.36-14.77
Capital Expenditures
----0-0.01-
Free Cash Flow
-12.31-10.85-12.19-11.14-13.37-14.77
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%--
Operating Margin
----5228.00%--
Pretax Margin
----4920.00%--
Profit Margin
----4920.00%--
FCF Margin
----4454.80%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---21.88--